These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37820832)

  • 1. Tofacitinib in the treatment of moderate to severe ulcerative colitis in Colombian pediatric patients: Real world experience.
    Parra-Izquierdo V; Frías-Ordoñez JS; Cuadros C; Vargas M; Vera Chamorro JF; Romero Sanchez C; Flórez-Sarmiento C
    Gastroenterol Hepatol; 2024; 47(6):574-581. PubMed ID: 37820832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colombian experience with the use of tofacitinib in severe acute ulcerative colitis: A case series study.
    Parra-Izquierdo V; Frías-Ordoñez JS; Juliao-Baños F; Cuadros C; Romero Sanchez C; Flórez-Sarmiento C
    Gastroenterol Hepatol; 2024; 47(6):582-590. PubMed ID: 37806342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tofacitinib in the treatment of moderate to severe ulcerative colitis in Colombia: Real world experience.
    Parra-Izquierdo V; Frías-Ordoñez JS; Márquez JR; Juliao-Baños F; Galindo P; Cuadros C; Rojas C; Rojas N; Ardila O; Tovar-Fierro G; García-Duperly R; Vargas M; Flórez-Sarmiento C
    Gastroenterol Hepatol; 2023; 46(7):512-521. PubMed ID: 36372256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tofacitinib for Rescue Therapy in Acute Severe Ulcerative Colitis: A Real-world Experience.
    Kotwani P; Terdiman J; Lewin S
    J Crohns Colitis; 2020 Jul; 14(7):1026-1028. PubMed ID: 32020189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon.
    Sharara AI; Alrazim A; Saniour P; Daniel F; Rached AA; Bahr A; Azar C; Geagea A; Ghoubar M
    BMC Gastroenterol; 2024 Oct; 24(1):349. PubMed ID: 39367371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian Study.
    Carvalhas Gabrielli AM; Ferretti F; Monico CM; Tombetti E; Maconi G; Romeo S; Piazza O Sed N; Caprioli F; Mazzola AM; Alicante S; Bertè R; Lolli E; Scribano ML; Buscarini E; Ricci C; Carmagnola S; Ardizzone S; Cannatelli R
    Dig Dis Sci; 2024 May; 69(5):1785-1792. PubMed ID: 38530500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world clinical efficacy of tofacitinib in moderate-to-severe ulcerative colitis.
    Lopes SR; Martins C; Teixeira M; Tomás D
    World J Gastroenterol; 2024 Sep; 30(34):3929-3931. PubMed ID: 39350781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
    Sandborn WJ; Su C; Sands BE; D'Haens GR; Vermeire S; Schreiber S; Danese S; Feagan BG; Reinisch W; Niezychowski W; Friedman G; Lawendy N; Yu D; Woodworth D; Mukherjee A; Zhang H; Healey P; Panés J;
    N Engl J Med; 2017 May; 376(18):1723-1736. PubMed ID: 28467869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Endoscopic Outcomes Through 78 Weeks of Tofacitinib Therapy for Ulcerative Colitis in a US Cohort.
    Dalal RS; Sharma PP; Bains K; Pruce JC; Allegretti JR
    Inflamm Bowel Dis; 2024 Oct; 30(10):1707-1713. PubMed ID: 37843044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry.
    Biemans VBC; Sleutjes JAM; de Vries AC; Bodelier AGL; Dijkstra G; Oldenburg B; Löwenberg M; van Bodegraven AA; van der Meulen-de Jong AE; de Boer NKH; Srivastava N; West RL; Römkens TEH; Horjus Talabur Horje CS; Jansen JM; van der Woude CJ; Hoekstra J; Weersma RK; van Schaik FDM; Hoentjen F; Pierik MJ;
    Aliment Pharmacol Ther; 2020 May; 51(9):880-888. PubMed ID: 32237087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis.
    Lair-Mehiri L; Stefanescu C; Vaysse T; Laharie D; Roblin X; Rosa I; Treton X; Abitbol V; Amiot A; Bouguen G; Dib N; Fumery M; Pariente B; Carbonnel F; Peyrin-Biroulet L; Simon M; Viennot S; Bouhnik Y
    Dig Liver Dis; 2020 Mar; 52(3):268-273. PubMed ID: 31732444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of tofacitinib treatment in ulcerative colitis.
    Panés J; Gisbert JP
    Gastroenterol Hepatol; 2019; 42(6):403-412. PubMed ID: 31101342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance study.
    Yoon H; Ye BD; Kang SB; Lee KM; Choi CH; Jo JY; Woo J; Cheon JH
    BMC Gastroenterol; 2024 Aug; 24(1):273. PubMed ID: 39160459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses.
    Pantavou K; Yiallourou AI; Piovani D; Evripidou D; Danese S; Peyrin-Biroulet L; Bonovas S; Nikolopoulos GK
    United European Gastroenterol J; 2019 Dec; 7(10):1285-1303. PubMed ID: 31839954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P056 Real life experience with the use of tofacitinib in ulcerative colitis in Colombia: case series.
    Parra Izquierdo V; Frias-Ordoñez J; Galindo P; Romero-Sanchez C; Florez C
    Am J Gastroenterol; 2021 Dec; 116(Suppl 1):S14-S15. PubMed ID: 37461974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience.
    Honap S; Chee D; Chapman TP; Patel M; Kent AJ; Ray S; Sharma E; Kennedy J; Cripps S; Walsh A; Goodhand JR; Ahmad T; Satsangi J; Irving PM; Kennedy NA;
    J Crohns Colitis; 2020 Oct; 14(10):1385-1393. PubMed ID: 32280965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis.
    Colombel JF; Osterman MT; Thorpe AJ; Salese L; Nduaka CI; Zhang H; Lawendy N; Friedman GS; Quirk D; Su C; Reinisch W
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):116-125.e5. PubMed ID: 33039585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tofacitinib is an effective treatment for moderate to severe ulcerative colitis, and intestinal ultrasound can discriminate response from non-response: a pragmatic prospective real-world study.
    Ollech JE; Eran-Banai H; Goren I; Sharar Fischler T; Avni-Biron I; Snir Y; Broitman Y; Cohen S; Friedenberg A; Pauker MH; Dotan I; Yanai H
    Ann Med; 2024 Dec; 56(1):2358183. PubMed ID: 38813808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes.
    Panés J; Su C; Bushmakin AG; Cappelleri JC; Mamolo C; Healey P
    BMC Gastroenterol; 2015 Feb; 15():14. PubMed ID: 25651782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study.
    Resál T; Bacsur P; Keresztes C; Bálint A; Bor R; Fábián A; Farkas B; Katsanos K; Michalopoylos G; Ribaldone DG; Attauabi M; Zhao M; Barak HA; Yanai H; Bezzio C; Rispo A; Castiglione F; Bar-Gil Shitrit A; Pugliese D; Armuzzi A; Savarino EV; Kolar M; Lukáš M; Chashkova E; Filip R; Rozieres A; Nancey S; Krznarić Ž; Schäfer E; Szamosi T; Sarlós P; Franko M; Drobne D; Knyazev OV; Kagramanova AV; Limdi J; Wetwittayakhlang P; Lakatos PL; Maharshak N; Bannon L; Nyári T; Szepes Z; Farkas K; ; Molnár T
    Inflamm Bowel Dis; 2024 May; 30(5):768-779. PubMed ID: 37542737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.